London hospital group partners with NHS England to provide Omicron support

Spire Healthcare Group PLC, a London based independent hospital group, announced that, at the request of NHS England, it has reached an agreement to provide support to the NHS and its patients during the ongoing COVID-19 pandemic.

This agreement follows detailed discussions with NHSE and other independent providers, in light of the uncertainties created by the Omicron variant.

While the final details of a new contract have yet to be agreed, it will operate on similar terms to the contract in place during January to March 2021 which was announced on December 21 2020.

The agreement in principle is for payment by activity based on NHS tariff, with minimum value underpins. Work under the agreement in principle will commence on Monday 10 January and expire on March 31 2022. There will be no extension or cancellation unless mutually agreed.

Under the agreement, Spire Healthcare, together with other independent providers, will continue to relieve pressure on NHS hospitals in England by treating NHS elective patients and providing urgent cancer work.

The agreement will allow Spire Healthcare to continue to treat private patients, whilst supporting the NHS.

If required, subject to meeting agreed criteria, Spire Healthcare will grant NHSE access to 100 per cent of its facilities and teams on a local, regional or national basis in the event of a surge of COVID-19 patients in NHS hospitals in England.

If a Spire Healthcare hospital is in surge, Spire Healthcare will receive 100 per cent cost recovery for its services.

Our Partners